Cantrill H L
Int Ophthalmol Clin. 1984 Winter;24(4):13-29.
The DRS showed that the benefit of panretinal photocoagulation outweighed the risks of therapy in eyes with high-risk characteristics. The ETDRS will demonstrate if photocoagulation earlier in the course of diabetic retinopathy is safe and efficacious. Criteria will be developed for determining which eyes with macular edema are responsive to photocoagulation. The data collected on the different laser treatments should establish which techniques are most effective and least harmful. Systemic aspirin therapy to retard or reverse retinopathy will be investigated in a controlled manner.
糖尿病视网膜病变研究显示，在具有高危特征的眼中，全视网膜光凝的益处超过了治疗风险。糖尿病视网膜病变早期治疗研究（ETDRS）将证明在糖尿病视网膜病变病程中更早进行光凝是否安全有效。将制定标准以确定哪些黄斑水肿的眼睛对光凝有反应。收集的关于不同激光治疗的数据应能确定哪些技术最有效且危害最小。将以对照方式研究全身性阿司匹林治疗延缓或逆转视网膜病变的效果。
